Secondary Prevention of Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Osteoporosis
Interventions
DRUG

alendronate with cholecalciferol

alendronate 70mg /cholecalciferol 2800IU orally once weekly

DRUG

calcium carbonate with cholecalciferol

calcium carbonate 500mg /cholecalciferol 200IU orally twice daily

BEHAVIORAL

Falls prevention measures

personalized exercises, home safety evaluation, referral to an eye doctor if needed, review of medications

Trial Locations (1)

02131

Hebrew SeniorLife, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Hebrew SeniorLife

OTHER

NCT00421343 - Secondary Prevention of Osteoporosis | Biotech Hunter | Biotech Hunter